Davis Investment Partners LLC Has $234,000 Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Davis Investment Partners LLC cut its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 427 shares of the medical equipment provider’s stock after selling 29 shares during the quarter. Davis Investment Partners LLC’s holdings in Intuitive Surgical were worth $234,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in the company. Jupiter Asset Management Ltd. acquired a new position in Intuitive Surgical during the second quarter worth approximately $364,000. Wealthspire Advisors LLC lifted its holdings in Intuitive Surgical by 10.9% during the 2nd quarter. Wealthspire Advisors LLC now owns 1,145 shares of the medical equipment provider’s stock valued at $509,000 after purchasing an additional 113 shares during the last quarter. Wrapmanager Inc. boosted its position in Intuitive Surgical by 8.1% during the second quarter. Wrapmanager Inc. now owns 811 shares of the medical equipment provider’s stock worth $361,000 after purchasing an additional 61 shares during the period. Prosperity Consulting Group LLC increased its holdings in shares of Intuitive Surgical by 24.4% in the second quarter. Prosperity Consulting Group LLC now owns 1,831 shares of the medical equipment provider’s stock valued at $815,000 after purchasing an additional 359 shares during the last quarter. Finally, J.W. Cole Advisors Inc. raised its position in shares of Intuitive Surgical by 37.2% in the second quarter. J.W. Cole Advisors Inc. now owns 2,767 shares of the medical equipment provider’s stock valued at $1,231,000 after purchasing an additional 750 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Intuitive Surgical

In related news, CEO Gary S. Guthart sold 18,151 shares of Intuitive Surgical stock in a transaction on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total value of $9,286,596.13. Following the transaction, the chief executive officer now directly owns 24,219 shares of the company’s stock, valued at $12,391,166.97. The trade was a 42.84 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Jamie Samath sold 22,903 shares of the company’s stock in a transaction that occurred on Friday, November 8th. The shares were sold at an average price of $525.00, for a total value of $12,024,075.00. Following the transaction, the insider now directly owns 8,757 shares of the company’s stock, valued at $4,597,425. The trade was a 72.34 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 48,190 shares of company stock valued at $25,012,927. Corporate insiders own 0.90% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms recently issued reports on ISRG. Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. The Goldman Sachs Group set a $604.00 price objective on shares of Intuitive Surgical in a report on Friday, October 18th. Leerink Partners raised their target price on shares of Intuitive Surgical from $489.00 to $502.00 in a report on Thursday, October 17th. Truist Financial increased their price target on Intuitive Surgical from $570.00 to $640.00 and gave the stock a “buy” rating in a research report on Wednesday, December 18th. Finally, BTIG Research lifted their price objective on Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a report on Tuesday, November 26th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have given a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $554.17.

Intuitive Surgical Trading Down 1.4 %

Shares of Intuitive Surgical stock traded down $7.72 on Monday, reaching $539.75. The stock had a trading volume of 1,387,774 shares, compared to its average volume of 1,350,754. The business’s 50 day moving average is $535.93 and its two-hundred day moving average is $495.17. The company has a market cap of $192.25 billion, a P/E ratio of 86.78, a price-to-earnings-growth ratio of 5.31 and a beta of 1.39. Intuitive Surgical, Inc. has a 1 year low of $355.17 and a 1 year high of $556.23.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. The firm had revenue of $2.04 billion during the quarter, compared to the consensus estimate of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. On average, equities analysts anticipate that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.